Our primary outcome was the incidence of seven major neurodegenerative diseases: Parkinsons disease, Alzheimers disease, Lewy body dementia, multiple sclerosis, amyotrophic lateral sclerosis, frontotemporal dementia, and Huntingtons disease
For patients receiving B12 replacement therapy for pernicious anaemia or deficiency , monitoring is typically arranged by the prescribing clinician
At 26 weeks, it was found that the group of participants who were in the Rybelsus 14mg group, had a 42% greater weight reduction compared to the liraglutide 1.8 mg group
doi: 10.1038/s41584-025-01326-6
We offer an a ffordable semaglutide weight loss program in Florida As with any medications the effect of GLP-1 medication will vary from patient to patient